|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.33 CNY | +0.19% |
|
+0.39% | -13.48% |
| 12-01 | Shanghai Shyndec Pharmaceutical Gets Registration for Opioid Analgesic | MT |
| 11-04 | Shyndec Pharmaceutical Buys Rights for Lactulose Oral Solution | MT |
Company Valuation: Shanghai Shyndec Pharmaceutical Co., Ltd.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 9,181 | 9,766 | 10,650 | 9,346 | 13,130 | 16,014 |
| Change | - | 6.38% | 9.04% | -12.25% | 40.5% | 21.96% |
| Enterprise Value (EV) 1 | 8,687 | 9,853 | 10,550 | 6,601 | 8,302 | 9,508 |
| Change | - | 13.42% | 7.07% | -37.43% | 25.77% | 14.53% |
| P/E ratio | 15.7x | 17.3x | 21.5x | 16.8x | 18x | 14.8x |
| PBR | 1.21x | 1.2x | 1.24x | 1.06x | 1.06x | 1.21x |
| PEG | - | -4.96x | -1.7x | 1.3x | 244.31x | 0.3x |
| Capitalization / Revenue | 0.75x | 0.78x | 0.76x | 0.72x | 1.09x | 1.46x |
| EV / Revenue | 0.71x | 0.78x | 0.76x | 0.51x | 0.69x | 0.87x |
| EV / EBITDA | 4.67x | 5.42x | 5.7x | 3.96x | 4.7x | 4.16x |
| EV / EBIT | 7.63x | 9x | 9.79x | 7.85x | 8.58x | 6.19x |
| EV / FCF | -26.2x | -97.5x | 17x | 4.04x | 4.62x | 5.7x |
| FCF Yield | -3.82% | -1.03% | 5.89% | 24.7% | 21.6% | 17.5% |
| Dividend per Share 2 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.3 |
| Rate of return | 1.12% | 1.05% | 0.96% | 1.1% | 1.02% | 2.51% |
| EPS 2 | 0.57 | 0.5501 | 0.4825 | 0.5429 | 0.5433 | 0.808 |
| Distribution rate | 17.5% | 18.2% | 20.7% | 18.4% | 18.4% | 37.1% |
| Net sales 1 | 12,199 | 12,556 | 13,945 | 12,959 | 12,070 | 10,938 |
| EBITDA 1 | 1,858 | 1,818 | 1,851 | 1,665 | 1,766 | 2,288 |
| EBIT 1 | 1,138 | 1,095 | 1,078 | 841.2 | 967.3 | 1,536 |
| Net income 1 | 656.4 | 648.8 | 568.3 | 627.8 | 691.9 | 1,084 |
| Net Debt 1 | -493.4 | 86.79 | -99.84 | -2,745 | -4,828 | -6,505 |
| Reference price 2 | 8.94 | 9.51 | 10.37 | 9.10 | 9.79 | 11.94 |
| Nbr of stocks (in thousands) | 1,026,937 | 1,026,958 | 1,026,964 | 1,026,983 | 1,341,173 | 1,341,173 |
| Announcement Date | 4/1/20 | 3/25/21 | 3/25/22 | 3/29/23 | 3/29/24 | 3/27/25 |
1CNY in Million2CNY
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| - | - | - | - | 1.96B | ||
| 18.33x | 2.86x | 10.03x | 1.91% | 61.02B | ||
| 23.92x | 2.33x | 10.44x | 2.36% | 8.57B | ||
| 11.69x | 6.09x | 9.22x | - | 7.45B | ||
| 58.96x | 14.33x | 43.87x | -.--% | 7.12B | ||
| 71.7x | 3.86x | 44.46x | 0.42% | 5.94B | ||
| 19.95x | 3.61x | 10.43x | -.--% | 4.38B | ||
| 35.14x | 5.97x | 19.67x | 0.76% | 2.84B | ||
| -59.07x | - | - | - | 2.62B | ||
| Average | 22.58x | 5.58x | 21.16x | 0.91% | 11.32B | |
| Weighted average by Cap. | 22.91x | 4.09x | 14.88x | 1.57% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Equities
- 600420 Stock
- Valuation Shanghai Shyndec Pharmaceutical Co., Ltd.
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















